Received: 26 May 2021
Accepted: 3 October 2021
First Online: 2 January 2022
: The present study was exempt from human-subjects review by our institutional review board (IRB).
: Consent to publish was obtained from all individual participants included in the study.
: V.S, J.R, and A.S have nothing to disclose. D.O holds stock or stock options in ROMTech. R.D is a paid consultant for Radlink, Schaerer Medical, Exactech, and Medtronics. R.S is a paid consultant for Smith & Nephew, and Intellijoint. He also has stock options in Gauss Surgical and PSI outside the submitted work<b>.</b> All authors were not involved in the journal’s review of or decisions related to this manuscript.